Citadel Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-111,500
| Closed | -$23.7M | – | 15584 |
|
|
2023
Q3 | $23.7M | Sell |
111,500
-228,000
| -67% | -$45.5M | 0.01% | 1690 |
|
|
2023
Q2 | $65.3M | Buy |
339,500
+299,300
| +745% | +$59.5M | 0.01% | 849 |
|
|
2023
Q1 | $8.14M | Sell |
40,200
-36,500
| -48% | -$5.85M | ﹤0.01% | 3080 |
|
|
2022
Q4 | $9.86M | Buy |
76,700
+49,900
| +186% | +$6.44M | ﹤0.01% | 2867 |
|
|
2022
Q3 | $3.67M | Sell |
26,800
-157,600
| -85% | -$25.7M | ﹤0.01% | 4412 |
|
|
2022
Q2 | $32.6M | Buy |
184,400
+152,300
| +474% | +$21.9M | 0.01% | 1407 |
|
|
2022
Q1 | $4.62M | Sell |
32,100
-32,400
| -50% | -$4.38M | ﹤0.01% | 4326 |
|
|
2021
Q4 | $9.97M | Sell |
64,500
-53,300
| -45% | -$8.92M | ﹤0.01% | 3078 |
|
|
2021
Q3 | $20M | Buy |
117,800
+70,700
| +150% | +$11M | ﹤0.01% | 1983 |
|
|
2021
Q2 | $7.44M | Sell |
47,100
-27,200
| -37% | -$4.04M | ﹤0.01% | 3627 |
|
|
2021
Q1 | $10.3M | Sell |
74,300
-10,100
| -12% | -$1.63M | ﹤0.01% | 2917 |
|
|
2020
Q4 | $14.8M | Sell |
84,400
-17,200
| -17% | -$3.21M | ﹤0.01% | 2144 |
|
|
2020
Q3 | $19.9M | Buy |
101,600
+10,100
| +11% | +$1.69M | 0.01% | 1577 |
|
|
2020
Q2 | $15.5M | Buy |
91,500
+46,700
| +104% | +$6.97M | 0.01% | 1738 |
|
|
2020
Q1 | $5.17M | Buy |
44,800
+4,100
| +10% | +$454K | ﹤0.01% | 2657 |
|
|
2019
Q4 | $4.65M | Sell |
40,700
-48,700
| -54% | -$5.16M | ﹤0.01% | 3165 |
|
|
2019
Q3 | $7.63M | Buy |
89,400
+47,600
| +114% | +$3.49M | ﹤0.01% | 2553 |
|
|
2019
Q2 | $2.89M | Sell |
41,800
-95,000
| -69% | -$6.65M | ﹤0.01% | 3916 |
|
|
2019
Q1 | $10M | Buy |
136,800
+107,200
| +362% | +$7.63M | 0.01% | 2074 |
|
|
2018
Q4 | $1.68M | Sell |
29,600
-800
| -3% | -$50.2K | ﹤0.01% | 4425 |
|
|
2018
Q3 | $2.34M | Buy |
30,400
+20,400
| +204% | +$1.5M | ﹤0.01% | 4139 |
|
|
2018
Q2 | $664K | Sell |
10,000
-8,000
| -44% | -$458K | ﹤0.01% | 5908 |
|
|
2018
Q1 | $942K | Sell |
18,000
-7,600
| -30% | -$414K | ﹤0.01% | 4908 |
|
|
2017
Q4 | $1.37M | Buy |
25,600
+1,300
| +5% | +$75.9K | ﹤0.01% | 4169 |
|
|
2017
Q3 | $1.32M | Sell |
24,300
-8,400
| -26% | -$430K | ﹤0.01% | 3932 |
|
|
2017
Q2 | $1.69M | Buy |
32,700
+18,900
| +137% | +$1.2M | ﹤0.01% | 3389 |
|
|
2017
Q1 | $867K | Sell |
13,800
-19,800
| -59% | -$1.24M | ﹤0.01% | 4218 |
|
|
2016
Q4 | $1.77M | Buy |
33,600
+16,500
| +96% | +$992K | ﹤0.01% | 3106 |
|
|
2016
Q3 | $924K | Sell |
17,100
-4,000
| -19% | -$190K | ﹤0.01% | 3938 |
|
|
2016
Q2 | $853K | Sell |
21,100
-32,700
| -61% | -$1.24M | ﹤0.01% | 3765 |
|
|
2016
Q1 | $1.89M | Sell |
53,800
-29,900
| -36% | -$1M | ﹤0.01% | 2701 |
|
|
2015
Q4 | $3.76M | Buy |
83,700
+22,600
| +37% | +$941K | ﹤0.01% | 2084 |
|
|
2015
Q3 | $2.36M | Sell |
61,100
-4,100
| -6% | -$185K | ﹤0.01% | 2741 |
|
|
2015
Q2 | $3.16M | Buy |
65,200
+22,500
| +53% | +$928K | ﹤0.01% | 2529 |
|
|
2015
Q1 | $1.51M | Sell |
42,700
-14,300
| -25% | -$488K | ﹤0.01% | 3429 |
|
|
2014
Q4 | $1.83M | Buy |
57,000
+200
| +0.4% | +$6.97K | ﹤0.01% | 3017 |
|
|
2014
Q3 | $2.11M | Buy |
56,800
+11,700
| +26% | +$460K | ﹤0.01% | 2797 |
|
|
2014
Q2 | $1.73M | Buy |
45,100
+32,000
| +244% | +$1.21M | ﹤0.01% | 2875 |
|
|
2014
Q1 | $597K | Sell |
13,100
-11,700
| -47% | -$560K | ﹤0.01% | 4093 |
|
|
2013
Q4 | $989K | Sell |
24,800
-2,500
| -9% | -$102K | ﹤0.01% | 3235 |
|
|
2013
Q3 | $1.2M | Buy |
27,300
+18,500
| +210% | +$770K | ﹤0.01% | 2909 |
|
|
2013
Q2 | $277K | Buy |
+8,800
| New | +$307K | ﹤0.01% | 4370 |
|
Other funds holding SGEN
SCM
IA
BTI
FBC
VWA
SAG
Citadel Advisors's SGEN Position: Q4 2023 in Review
Citadel Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 2,428,418 shares — an estimated $515M sold.
Citadel Advisors first reported a position in SGEN in Q2 2013 and held it in 39 quarters. The position peaked at $515M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.
- Citadel Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 2,428,418 Seagen Inc. Common Stock shares in Q4 2023, an estimated $515M.
- Citadel Advisors first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Seagen Inc. Common Stock position peaked at $515M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.